A Yeast Surface Display Platform for Screening Dimeric Mammalian Receptors

preprint OA: closed
⚙ AI-generated summary by claude@2026-07, 2026-07-05 ⓘ

This paper describes a yeast surface display platform engineered for high-throughput screening of dimeric mammalian receptors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-05 · read from full text ⓘ

The paper develops a high-throughput yeast surface display platform to screen proteins that modulate dimeric mammalian receptors by moving beyond binding-only selection to capture receptor activation or inhibition. Using engineered induction pathways, it programs dimerization of mammalian receptor extracellular domains on yeast, enabling receptor expression and secretion of associated native cytokines, and then infers activation via DNA-driven signaling cascade expectations in mammalian cells. The main caveat is that the yeast platform relies on the engineered dimerization and downstream signaling readouts rather than directly characterizing signaling in a native cellular receptor context. Relevance to endometriosis: the paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Discovering proteins that modulate receptor activity remains a key challenge in the field of protein design and engineering. Traditionally, identifying proteins that interact with receptors often relies on binding as a selection criterion, yielding limited information about the function of discovered binders in a library, including the ability to activate or block signaling cascades associated with the receptor of interest. As a result, extensive downstream characterization is required to assess the biological relevance of discovered binders. To address this issue, we have developed a high-throughput screening system to screen dimeric mammalian receptors using yeast surface display. We demonstrate the programmed dimerization of the extracellular domains of mammalian receptors in yeast via engineered induction pathways, thereby enabling receptor expression and the secretion of associated native cytokines. This surface expression of the involved subunits for the protein receptor and cytokine-induced dimerization activity indicates that the receptor has been activated and is expected to trigger a DNA-driven signaling cascade within a mammalian cell. This system provides a modular platform technology that advances existing yeast-display systems, demonstrating the effectiveness of these high-throughput platforms for screening the function of mammalian receptors. This work is expected to provide a rapid, cost-effective approach to the molecular discovery of novel biologics for targeting dimeric mammalian receptors.
Full text 1,782 characters · extracted from oa-doi-fallback · click to expand
Abstract Discovering proteins that modulate receptor activity remains a key challenge in the field of protein design and engineering. Traditionally, identifying proteins that interact with receptors often relies on binding as a selection criterion, yielding limited information about the function of discovered binders in a library, including the ability to activate or block signaling cascades associated with the receptor of interest. As a result, extensive downstream characterization is required to assess the biological relevance of discovered binders. To address this issue, we have developed a high-throughput screening system to screen dimeric mammalian receptors using yeast surface display. We demonstrate the programmed dimerization of the extracellular domains of mammalian receptors in yeast via engineered induction pathways, thereby enabling receptor expression and the secretion of associated native cytokines. This surface expression of the involved subunits for the protein receptor and cytokine-induced dimerization activity indicates that the receptor has been activated and is expected to trigger a DNA-driven signaling cascade within a mammalian cell. This system provides a modular platform technology that advances existing yeast-display systems, demonstrating the effectiveness of these high-throughput platforms for screening the function of mammalian receptors. This work is expected to provide a rapid, cost-effective approach to the molecular discovery of novel biologics for targeting dimeric mammalian receptors. Competing Interest Statement E.S., E.K., and B.R.K. are inventors on U.S. Invention Disclosure IDF-072218 for the design of yeast-based receptor systems for nanobody engineering of agonistic and antagonistic-induced dimerization activity.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-07-15T06:44:59.916582+00:00